Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase

Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase

US Patent 9687490 · Granted Jun 27, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonamide derivatives having selective Nox inhibiting activity2025
Sulfonamide derivatives having selective Nox inhibiting activity2025
Compounds for use in the treatment of conditions associated with NADPH oxidase2019
Compounds for use in the treatment of conditions associated with NADPH oxidase2019
Compounds for use in the treatment of conditions associated with NADPH oxidase2019
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,42019
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,42019
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,42019
Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase2007
Identification of agents that increase glucose uptake2005
Speech immunity enhancement in linear prediction based DTMF detector2000
Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential1999